Inventor · disambiguated record
Kurt Ritter
Also filed as: RITTER KURT
44 granted patents·15 pending applications·1,246 citations·filing 1994–2024
98Inventor score
Top patents by PatentIndex Score
59 records- 0198US6921763B2Pyrazolopyrimidines as therapeutic agentsABBOTT LAB·Filed 2001·Granted Jul 26, 2005·275 cites·132 claims
- 0298US6660744B1Pyrazolopyrimidines as therapeutic agentsABBOTT GMBH & CO KG·Filed 2000·Granted Dec 9, 2003·331 cites·86 claims
- 0397US7332497B2Pyrazolopyrimidines as therapeutic agentsABBOTT GMBH & CO KG·Filed 2002·Granted Feb 19, 2008·217 cites·24 claims
- 0492US7071199B1Kinase inhibitors as therapeutic agentsABBOTT GMBH & CCO KG·Filed 2000·Granted Jul 4, 2006·85 cites·69 claims
- 0589US11897876B2Isoxazolidines as RIPK1 inhibitors and use thereofGENZYME CORP·Filed 2022·Granted Feb 13, 2024·1 cites·27 claims
- 0688US7317027B2Azaindole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jan 8, 2008·26 cites·10 claims
- 0787US6906084B2Indole derivatives as factor Xa inhibitorsAVENTIS PHARMA GMBH·Filed 2002·Granted Jun 14, 2005·30 cites·8 claims
- 0886US7935819B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2008·Granted May 3, 2011·15 cites·12 claims
- 0986US7354933B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2004·Granted Apr 8, 2008·27 cites·58 claims
- 1085US7196103B2Indole derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Mar 27, 2007·27 cites·15 claims
- 1184US8828994B2Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereofBOEHME THOMAS·Filed 2012·Granted Sep 9, 2014·4 cites·12 claims
- 1282US5502032APeptides, the preparation and use thereofBASF AG·Filed 1994·Granted Mar 26, 1996·52 cites·13 claims
- 1379US7368528B2Antineoplastic peptidesABBOTT GMBH & CO KG·Filed 2005·Granted May 6, 2008·2 cites·2 claims
- 1479US5965537ADolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminusBASF AG·Filed 1997·Granted Oct 12, 1999·37 cites·21 claims
- 1578US7807779B2Antineoplastic peptidesABBOTT GMBH & CO KG·Filed 2008·Granted Oct 5, 2010·2 cites·4 claims
- 1677US2025122186A1Isoxazolidines as ripk1 inhibitors and use thereofGENZYME CORP·Filed 2024·Application pending·0 cites
- 1776US10392366B2Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2018·Granted Aug 27, 2019·2 cites·44 claims
- 1875US5985837ADolastatin 15 derivativesBASF AG·Filed 1998·Granted Nov 16, 1999·34 cites·21 claims
- 1975US5622953A1-amino-3-phenoxy propane derivatives as modulator agents and their applicationsBASF AG·Filed 1995·Granted Apr 22, 1997·22 cites·4 claims
- 2074US9896434B2Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2015·Granted Feb 20, 2018·2 cites·14 claims
- 2174US2024109882A1Isoxazolidines as ripk1 inhibitors and use thereofGENZYME CORP·Filed 2023·Application pending·0 cites
- 2271US7825115B2Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2008·Granted Nov 2, 2010·1 cites·56 claims
- 2369US7759379B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2007·Granted Jul 20, 2010·1 cites·18 claims
- 2468US9758520B2Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2016·Granted Sep 12, 2017·1 cites·31 claims
- 2566US7400979B2Method of identifying inhibitors of LckABBOTT LAB·Filed 2002·Granted Jul 15, 2008·1 cites·3 claims
- 2661US2008280946A1Azaindole-Derivatives As Factor Xa InhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 2760US2009069565A1New indole derivatives as factor xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 2858US5886147ACompounds useful for the synthesis of dolastatin analogsBASF AG·Filed 1995·Granted Mar 23, 1999·9 cites·1 claims
- 2957US8440626B2Antineoplastic peptidesAMBERG WILHELM·Filed 2010·Granted May 14, 2013·0 cites·18 claims
- 3055US8501736B2Isoquinoline derivativesPLETTENBURG OLIVER·Filed 2007·Granted Aug 6, 2013·0 cites·42 claims
- 3155US5965700APreparation of active peptidesBASF AG·Filed 1996·Granted Oct 12, 1999·8 cites·9 claims
- 3255US2005043302A1New indole derivatives as factor Xa inhibitorsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 3354US6248865B1Compounds useful for the synthesis of dolastatin analogsBASF AG·Filed 1998·Granted Jun 19, 2001·6 cites·3 claims
- 3454US2023219937A1Isoxazolidines as ripk1 inhibitors and use thereofSANOFI SA·Filed 2021·Application pending·0 cites
- 3552US2007037120A1Facial support deviceRITTER KURT·Filed 2005·Application pending·0 cites
- 3648US2001009901A1Antineoplastic peptidesBASF AG GERMANY·Filed 2001·Application pending·0 cites
- 3747US8828995B2Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereofBOEHME THOMAS·Filed 2012·Granted Sep 9, 2014·0 cites·12 claims
- 3847US5864012AActive peptide and its preparationBASF AG·Filed 1995·Granted Jan 26, 1999·7 cites·5 claims
- 3947US2009082329A1Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase InhibitorsAVENTIS PHARMA SA·Filed 2008·Application pending·0 cites
- 4046US8895547B2Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereofBOEHME THOMAS·Filed 2012·Granted Nov 25, 2014·0 cites·12 claims
- 4146US8722671B2Isoquinoline derivativesPLETTENBURG OLIVER·Filed 2011·Granted May 13, 2014·0 cites·25 claims
- 4246US7910602B2Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1SANOFI AVENTIS·Filed 2007·Granted Mar 22, 2011·0 cites·14 claims
- 4346US2001018422A1Dolastatin 15 derivativesBASF AG·Filed 2001·Application pending·0 cites
- 4445US2008021029A1Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase InhibitorsAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 4544US7741341B2Benzimidazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jun 22, 2010·0 cites·19 claims
- 4644US5807984AOligopeptides, the preparation and use thereofBASF AG·Filed 1995·Granted Sep 15, 1998·10 cites·5 claims
- 4744US2007259891A1Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase InhibitorsAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 4843US8901114B2Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereofBOEHME THOMAS·Filed 2012·Granted Dec 2, 2014·0 cites·11 claims
- 4942US8871758B2Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereofBOEHME THOMAS·Filed 2012·Granted Oct 28, 2014·0 cites·12 claims
- 5042US8710050B2Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereofBOEHME THOMAS·Filed 2012·Granted Apr 29, 2014·0 cites·12 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kurt Ritter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →